I have a feeling ResMed and RAP will make a deal happen. The results were actually slightly better than I thought. If ResMed give RAP a revenue stream it gives the market confidence there won't be another CR in the future, therefore, upward momentum won't be thwarted by a CR (a CR may never happen, just looking at different scenarios).
What's your thoughts on how RAP should approach the OSA side of the business? Whoever I missed below feel free to have your input...
@Red bar
@RNClarke
@MSIMaker
@wop
@AICp
@Deadant
@silverfox3731
Ann: Positive Results from At-Home Sleep Apnoea Study, page-57
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #